Skip to content
Vinony
English
EnglishDeutschEspañolFrançaisItalianoNederlandsPolskiPortuguêsTiếng Việtالعربية日本語
EntityQ409697· pop 16· linked from 67 articles

pegvisomant

Sign in to save

Also known as GH-N, Growth hormone, GH, Pituitary growth hormone, Somatotropin precursor, Growth hormone 1, B2036-PEG

Pegvisomant, sold under the brand name Somavert, is a growth hormone receptor antagonist used in the treatment of acromegaly. It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy. It is delivered as a powder that is mixed with water and injected under the skin.

~2 min read

Encyclopedic overview

8 sections
Contents
  • Medical uses
  • Side effects
  • Discovery
  • Structure
  • Mechanism of action
  • Research
  • References
  • External links

Pegvisomant, sold under the brand name Somavert, is a growth hormone receptor antagonist used in the treatment of acromegaly. It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy. It is delivered as a powder that is mixed with water and injected under the skin.

== Medical uses == Pegvisomant is indicated for the treatment of adults with acromegaly.

Excerpted from Wikipedia’s “pegvisomant” article, available under the CC BY-SA 4.0 licence.

Available in 16 languages

via Wikidata sitelinks · CC0